Skip to main content

Table 4 Overall response to induction treatment and concurrent radiochemotherapy

From: Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study

Response

N.

(%)

Induction Treatment

  

Complete

9

(20.9)

Partial

23

(53.5)

Overall response

32

(74.4)

Stable Disease

10

(23.3)

Progression Disease

1

(2.3)

After concurrent radiochemotherapy

  

Complete

22

(51.2)

Partial

20

(46.5)

Overall response

42

(97.7)

Stable Disease

1

(2.3)

Progression Disease

0

(0)